NCT05651971

Brief Summary

  1. 1.To observe and measure the distance between the origin of LCA (left colonic artery,LCA) and IMA (inferior mesenteric artery,IMA) root and the distance between IMA and IMV (inferior mesenteric vein,IMV) at the origin of LCA in rectal cancer patients. Statistical analysis of intraoperative measured data, on the basis of the original anatomical relationship, to achieve anatomical localization of quantitative and accurate, for the preservation of LCA laparoscopic radical resection of rectal cancer to provide a strong anatomical basis.
  2. 2.The operation time, 253 lymph node dissection time, intraoperative blood loss, postoperative anal exhaust time, postoperative feeding time, postoperative hospital stay, postoperative ischemic colitis rate and postoperative anastomotic leakage rate of patients with laparoscopic radical resection of rectal cancer with preservation of LCA were recorded. The surgical efficacy and clinical significance of laparoscopic radical resection of rectal cancer with preservation of LCA were evaluated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2022

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

November 16, 2022

Completed
29 days until next milestone

First Posted

Study publicly available on registry

December 15, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

December 15, 2022

Status Verified

December 1, 2022

Enrollment Period

2.1 years

First QC Date

November 16, 2022

Last Update Submit

December 13, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Distance between LCA and IMA

    Measurement of the distance between the origin of LCA (left colonic artery,LCA) and IMA (inferior mesenteric artery,IMA) root

    intraoperative

  • The distance from LCA to IMA and IMV

    Measurement of the distance between IMA and IMV (inferior mesenteric vein,IMV) at the origin of LCA

    intraoperative

Secondary Outcomes (7)

  • operation time

    intraoperative

  • 253 lymph node dissection time

    intraoperative

  • intraoperative blood loss

    intraoperative

  • exhaust time

    Within one week after operation

  • postoperative feeding time

    Within one week after operation

  • +2 more secondary outcomes

Interventions

Measurement of the distance between the origin of LCA (left colonic artery,LCA) and IMA (inferior mesenteric artery,IMA) root and the distance between IMA and IMV (inferior mesenteric vein,IMV) at the origin of LCA in rectal cancer patients

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The age was between 18 and 75 years old, and the pathological diagnosis was rectal cancer (T2-4a, N- / +, M0)

You may qualify if:

  • Pathological diagnosis of rectal cancer (T2-4a, N- / +, M0) ; Laparoscopic radical resection of rectal cancer and preservation of LCA Patients and their families agree to participate in the clinical study

You may not qualify if:

  • Those who had a history of lower abdominal surgery and could not undergo laparoscopic surgery LCA vascular absence was found during operation combined with other malignant tumors pregnant or lactating patients Combined with severe mental illness Severe diseases of the blood system, coagulation dysfunction ; Preoperative assessment of heart, lung and brain function, unable to tolerate surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

General Surgery Gastriontestinal Department, Tang-Du of Fourth Medical University

Xi’an, Shanxi, 710038, China

RECRUITING

MeSH Terms

Conditions

Rectal Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 16, 2022

First Posted

December 15, 2022

Study Start

November 1, 2022

Primary Completion

December 1, 2024

Study Completion

December 31, 2025

Last Updated

December 15, 2022

Record last verified: 2022-12

Locations